Dosage Study for Vigamox Eye Drops Prior to Intravitreal Injections

To Compare the Efficacy of Topical Vigamox Eye Drops at Tid 3 Days Prior to Intravitreal Injection Versus Tid 1 Day Prior to Intravitreal Injection

Status

Completed

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00690313

Enrollment

Registered

2008-06-04

Start date

2008-08-31

Completion date

2011-04-30

Last updated

2019-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intravitreal Injection Patients

Keywords

Vigamox, topical antibiotics, Intravitreal injections, macular degeneration, endophthalmitis

Brief summary

Antibiotic eye drops are being used before and after intravitreal injections. Currently there is no study indicating the benefit of there usage or their dosage. In this study we compare the efficacy of Vigamox eye drops (antibiotic)starting 3 days prior to the injection versus 1 day prior to intravitreal injection.

Interventions

DRUGVigamox

eye drops 3 times day either 1 or 3 days prior to intravitreal injection

Study design

Allocation

NON_RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

21 Years to 100 Years

Healthy volunteers

Inclusion criteria

* Patient who need intravitreal injections patients who are willing to participate in the study

Exclusion criteria

* Patients who are allergic to Vigamox or who have taken any eye drops within the past 3 weeks

Design outcomes

Primary

Measure	Time frame
Timed study	1 year

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026